KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$13.4 million.

  • BioNTech SE's Cash from Financing Activities fell 5495.89% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.8 million, marking a year-over-year increase of 875.2%. This contributed to the annual value of -$49.0 million for FY2024, which is 9414.5% up from last year.
  • Per BioNTech SE's latest filing, its Cash from Financing Activities stood at -$13.4 million for Q3 2025, which was down 5495.89% from -$15.1 million recorded in Q2 2025.
  • BioNTech SE's 5-year Cash from Financing Activities high stood at $184.1 million for Q2 2021, and its period low was -$833.9 million during Q2 2022.
  • Over the past 5 years, BioNTech SE's median Cash from Financing Activities value was -$13.9 million (recorded in 2023), while the average stood at -$117.2 million.
  • The largest annual percentage gain for BioNTech SE's Cash from Financing Activities in the last 5 years was 166032932213.35% (2022), contrasted with its biggest fall of 11800113597.83% (2022).
  • Over the past 5 years, BioNTech SE's Cash from Financing Activities (Quarter) stood at $55.94 in 2021, then crashed by 118001135.98% to -$66.0 million in 2022, then skyrocketed by 78.97% to -$13.9 million in 2023, then skyrocketed by 43.8% to -$7.8 million in 2024, then crashed by 72.34% to -$13.4 million in 2025.
  • Its Cash from Financing Activities stands at -$13.4 million for Q3 2025, versus -$15.1 million for Q2 2025 and -$14.5 million for Q1 2025.